Why the study?
Heart failure with preserved ejection fraction is rapidly growing without evidence-based drug therapies to improve clinical outcomes, though exercise training effectively improves peak oxygen uptake, aerobic endurance, and quality of life.
Does exercise training improve peak oxygen uptake and quality of life in clinically stable patients with HFpEF?
Does exercise training improve peak oxygen uptake and quality of life in clinically stable patients with HFpEF?
This review highlights that while no evidence-based drug therapies exist to improve clinical outcomes in HFpEF, exercise training effectively improves exercise tolerance and quality of life.
Answers are grounded in this paper and cite their sources.
Exercise training improves exercise tolerance in HFpEF lacking drug options; leaves open optimal protocols and hard-endpoint trials.
Heart failure with preserved ejection fraction (HFpEF) is the fastest growing form of heart failure in the United States. The cardinal feature of HFpEF is reduced exercise tolerance (peak oxygen uptake, (Equation is included in full-text article.)O2peak) secondary to impaired cardiac, vascular, and skeletal muscle function. There are currently no evidence-based drug therapies to improve clinical outcomes in patients with HFpEF. In contrast, exercise training is a proven effective intervention for improving (Equation is included in full-text article.)O2peak, aerobic endurance, and quality of life in HFpEF patients. This brief review discusses the pathophysiology of exercise intolerance and the role of exercise training to improve (Equation is included in full-text article.)O2peak in clinically stable HFpEF patients. It also discusses the mechanisms responsible for the exercise training-mediated improvements in (Equation is included in full-text article.)O2peak in HFpEF. Finally, it provides evidence-based exercise prescription guidelines for cardiac rehabilitation specialists to assist them with safely implementing exercise-based cardiac rehabilitation programs for HFpEF patients.
No takes yet. Share an insight, caveat, or question.
Tucker et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: